As the global economy recovers in 2021 and the supply of the industrial chain improves, the Protein and Peptide Therapeutics market will undergo major changes. According to the latest research, the market size of the Protein and Peptide Therapeutics industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Protein and Peptide Therapeutics industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Protein and Peptide Therapeutics market during the next few years. The global Protein and Peptide Therapeutics market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of Protein and Peptide Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Protein and Peptide Therapeutics Market Size 2017-2028
2.1.2 Protein and Peptide Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Protein and Peptide Therapeutics Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Protein and Peptide Therapeutics Market Size by Type
2.3.1 Protein and Peptide Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Protein and Peptide Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Protein and Peptide Therapeutics Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Protein and Peptide Therapeutics Market Size by Application
2.5.1 Protein and Peptide Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Protein and Peptide Therapeutics Market Size Market Share by Application (2017-2022)
3 Protein and Peptide Therapeutics Market Size by Player
3.1 Protein and Peptide Therapeutics Market Size Market Share by Players
3.1.1 Global Protein and Peptide Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Protein and Peptide Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Protein and Peptide Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Protein and Peptide Therapeutics by Regions
4.1 Protein and Peptide Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.3 APAC Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.4 Europe Protein and Peptide Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Protein and Peptide Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Protein and Peptide Therapeutics Market Size by Country (2017-2022)
5.2 Americas Protein and Peptide Therapeutics Market Size by Type (2017-2022)
5.3 Americas Protein and Peptide Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Protein and Peptide Therapeutics Market Size by Region (2017-2022)
6.2 APAC Protein and Peptide Therapeutics Market Size by Type (2017-2022)
6.3 APAC Protein and Peptide Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Protein and Peptide Therapeutics by Country (2017-2022)
7.2 Europe Protein and Peptide Therapeutics Market Size by Type (2017-2022)
7.3 Europe Protein and Peptide Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Protein and Peptide Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Protein and Peptide Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Protein and Peptide Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Protein and Peptide Therapeutics Market Forecast
10.1 Global Protein and Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Protein and Peptide Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Protein and Peptide Therapeutics Forecast
10.1.3 APAC Protein and Peptide Therapeutics Forecast
10.1.4 Europe Protein and Peptide Therapeutics Forecast
10.1.5 Middle East & Africa Protein and Peptide Therapeutics Forecast
10.2 Americas Protein and Peptide Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Protein and Peptide Therapeutics Market Forecast
10.2.2 Canada Protein and Peptide Therapeutics Market Forecast
10.2.3 Mexico Protein and Peptide Therapeutics Market Forecast
10.2.4 Brazil Protein and Peptide Therapeutics Market Forecast
10.3 APAC Protein and Peptide Therapeutics Forecast by Region (2023-2028)
10.3.1 China Protein and Peptide Therapeutics Market Forecast
10.3.2 Japan Protein and Peptide Therapeutics Market Forecast
10.3.3 Korea Protein and Peptide Therapeutics Market Forecast
10.3.4 Southeast Asia Protein and Peptide Therapeutics Market Forecast
10.3.5 India Protein and Peptide Therapeutics Market Forecast
10.3.6 Australia Protein and Peptide Therapeutics Market Forecast
10.4 Europe Protein and Peptide Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Protein and Peptide Therapeutics Market Forecast
10.4.2 France Protein and Peptide Therapeutics Market Forecast
10.4.3 UK Protein and Peptide Therapeutics Market Forecast
10.4.4 Italy Protein and Peptide Therapeutics Market Forecast
10.4.5 Russia Protein and Peptide Therapeutics Market Forecast
10.5 Middle East & Africa Protein and Peptide Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Protein and Peptide Therapeutics Market Forecast
10.5.2 South Africa Protein and Peptide Therapeutics Market Forecast
10.5.3 Israel Protein and Peptide Therapeutics Market Forecast
10.5.4 Turkey Protein and Peptide Therapeutics Market Forecast
10.5.5 GCC Countries Protein and Peptide Therapeutics Market Forecast
10.6 Global Protein and Peptide Therapeutics Forecast by Type (2023-2028)
10.7 Global Protein and Peptide Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Protein and Peptide Therapeutics Product Offered
11.1.3 Sanofi Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Protein and Peptide Therapeutics Product Offered
11.2.3 Teva Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Information
11.3.2 Novo Nordisk Protein and Peptide Therapeutics Product Offered
11.3.3 Novo Nordisk Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novo Nordisk Main Business Overview
11.3.5 Novo Nordisk Latest Developments
11.4 Takeda
11.4.1 Takeda Company Information
11.4.2 Takeda Protein and Peptide Therapeutics Product Offered
11.4.3 Takeda Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Main Business Overview
11.4.5 Takeda Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Protein and Peptide Therapeutics Product Offered
11.5.3 Eli Lilly Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Protein and Peptide Therapeutics Product Offered
11.6.3 AstraZeneca Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Protein and Peptide Therapeutics Product Offered
11.7.3 Novartis Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Protein and Peptide Therapeutics Product Offered
11.8.3 AbbVie Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Ipsen
11.9.1 Ipsen Company Information
11.9.2 Ipsen Protein and Peptide Therapeutics Product Offered
11.9.3 Ipsen Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Ipsen Main Business Overview
11.9.5 Ipsen Latest Developments
11.10 Ferring
11.10.1 Ferring Company Information
11.10.2 Ferring Protein and Peptide Therapeutics Product Offered
11.10.3 Ferring Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ferring Main Business Overview
11.10.5 Ferring Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Protein and Peptide Therapeutics Product Offered
11.11.3 Merck Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 The Medicines
11.12.1 The Medicines Company Information
11.12.2 The Medicines Protein and Peptide Therapeutics Product Offered
11.12.3 The Medicines Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 The Medicines Main Business Overview
11.12.5 The Medicines Latest Developments
11.13 J & J
11.13.1 J & J Company Information
11.13.2 J & J Protein and Peptide Therapeutics Product Offered
11.13.3 J & J Protein and Peptide Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 J & J Main Business Overview
11.13.5 J & J Latest Developments
12 Research Findings and Conclusion
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
*If Applicable.